Shares of Teladoc Health fell over 12% on February 20 following the publication of a Blue Orca Capital report alleging the company has misled investors about its BetterHelp platform and financial reporting. The report claims that BetterHelp has used AI-generated responses in place of licensed therapists without proper disclosures to investors and patients and, among other allegations, the report accuses Teladoc of inflating profitability by shifting R&D expenses. Block & Leviton is investigating.
Contact our attorneys for a no-cost case evaluation.